|
| Seizure model | Age | Region | Effects on GABAA receptors | Ref. |
|
| Ictal changes |
|
| In vivo SE (Lithium-pilocarpine; continuous hippocampal stimulation) | PN30 | Hippocampus | Reduced surface expression of β2/3, γ2 subunits but not of δ. | [139] |
| In vivo SE (lithium-pilocarpine) | 4–7 week old | Hippocampus | Internalization of β2/3, γ2 subunits; reduced mIPSCs | [140] |
|
| After seizures |
|
| Recurrent flurothyl seizures | PN1-5 | Hippocampus, somatosensory cortex | Decreased amplitude of GABAergic IPSCs | [141, 142] |
| Flurothyl seizures | PN6 or PN6-10 | Hippocampus | Decreased numbers of α1-ir neurons | [143] |
| Kainic acid SE | PN9 | Hippocampus | At 3 weeks postictally: α1, α4, γ2 decrease; α2, α3 increase; α5 increase (CA3 only); β3 increase compared to controls | [144] |
| Lithium-pilocarpine | PN10 | Hippocampus (dentate gyrus) | In adulthood: increased α1 expression, larger GABA current, enhanced zolpidem sensitivity | [145] |
| Lithium-pilocarpine SE | PN20 | Hippocampus | Decreased α1 and increased α4 expression in the hippocampus of epileptic versus non-epileptic rats | [146] |
|